Please login to the form below

Not currently logged in
Email:
Password:

Epanova

This page shows the latest Epanova news and features for those working in and with pharma, biotech and healthcare.

FDA starts speedy review of Lynparza plus Avastin in ovarian cancer

FDA starts speedy review of Lynparza plus Avastin in ovarian cancer

Epanova trial disappoints. There was disappointing news as well for AZ at the start of this week however, after it announced it had decided to abandon the STRENGTH trial of Epanova – ... Epanova was acquired by AZ in its $443m takeover of Omthera in

Latest news

  • FDA approves AZ’s fish oil drug FDA approves AZ’s fish oil drug

    Epanova gets green light to reduce high levels of fat in the blood. ... Epanova is one of several pipeline-boosting drugs acquired by AZ over the past couple of years since Pascal Soriot took over as CEO.

  • Teva launches first generic of GSK's Lovaza in US Teva launches first generic of GSK's Lovaza in US

    Also affected is AstraZeneca, which filed for approval of its own triglyceride-lowering drug Epanova last year. ... AZ acquired Epanova along with developer Omthera Pharmaceuticals in July 2013 in a $443m deal.

  • FDA to review AZ's fish oil drug Epanova FDA to review AZ's fish oil drug Epanova

    The US Food and Drug Administration (FDA) will assess Epanova for use in the treatment of patients with severe hypertriglyceridaemia – an excess of fatty molecules called triglycerides in the blood. ... At the time, Epanova was noted as the company's

  • AZ target Omthera files blood fat drug in US

    FDA submission for Epanova in severe hypertriglyceridemia. Omthera Pharmaceuticals said yesterday it had submitted its drug Epanova for US approval in the treatment of patients with high levels of the blood ... Epanova has one potential advantage over

  • AstraZeneca offers $443m to buy Omthera AstraZeneca offers $443m to buy Omthera

    If finalised, AZ will take control of the drug candidate Epanova, which has completed phase III testing and is ready for regulatory submissions to treat elevated blood triglycerides. ... Epanova is an omega-3 free fatty acid composition that has been

More from news
Approximately 4 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Treatment and prevention of cardiovascular disease Treatment and prevention of cardiovascular disease

    By contrast, the recent STRENGTH trial (Statin Residual Risk Reduction with EpaNova in High Cardiovascular Risk Patients with Hypertriglyceridemia) ‘was terminated early due to interim analysis revealing low probability for benefit

  • Pharma deals during May 2014 Pharma deals during May 2014

    One year ago AstraZeneca acquired Omthera. On May 7 Epanova, a soft gelation capsule containing Omega-3, was approved by the FDA as an adjunct to diet to reduce triglyceride levels

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...